Case Study Marketing Authorization Transfer
In this client success story, a mid-sized biopharma company acquired an existing product portfolio from another company. There were eight products initially, spanning over 30 countries, focused on cardiovascular and transdermal patches. By using a flexible resourcing model we enabled cost and resource efficiencies in this marketing authorization transfer project.
Related Insights
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Case Study
Case Study Lifecycle maintenance
Nov 25, 2021
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Related Insights
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Case Study
Case Study Lifecycle maintenance
Nov 25, 2021
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023